Atlas Trials

GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study

Clinical trial NCT02525861 · COMPLETED

Trial details

NCT number
NCT02525861
Sponsor
Baxalta now part of Shire
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Alpha1-antitrypsin Deficiency
Start date
2016-03-08
Primary completion
2020-07-29
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.